MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

MC

536.1

+1.48%↑

CABK

11.205

-2.61%↓

INGA

25.56

-2.09%↓

NDA.FI

16.65

-1.77%↓

BKT

14.705

-1.21%↓

Search

Gimv NV

Aperta

SettoreFinanza

44.1 -0.68

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

44

Massimo

44.9

Metriche Chiave

By Trading Economics

Entrata

127M

Vendite

-49M

65M

P/E

Media del settore

7.709

27.185

EPS

3.4

Rendimento da dividendi

5.71

Margine di Profitto

195.239

Dipendenti

94

EBITDA

52M

128M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

5.71%

4.21%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

53M

1.7B

Apertura precedente

44.78

Chiusura precedente

44.1

Notizie sul Sentiment di mercato

By Acuity

50%

50%

171 / 445 Classifica in Finance

Gimv NV Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 feb 2026, 00:00 UTC

Azioni calde

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 feb 2026, 22:55 UTC

Utili

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 feb 2026, 21:44 UTC

Utili

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 feb 2026, 21:39 UTC

Utili

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 feb 2026, 00:00 UTC

Utili

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 feb 2026, 00:00 UTC

Utili

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 feb 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 feb 2026, 23:45 UTC

Utili

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 feb 2026, 23:32 UTC

Discorsi di Mercato

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 feb 2026, 22:59 UTC

Acquisizioni, Fusioni, Takeovers

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 feb 2026, 22:30 UTC

Utili

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 feb 2026, 22:30 UTC

Utili

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 feb 2026, 22:21 UTC

Utili

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb 2026, 22:17 UTC

Discorsi di Mercato

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 feb 2026, 22:15 UTC

Discorsi di Mercato

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 feb 2026, 22:00 UTC

Discorsi di Mercato

ESG Roundup: Market Talk

4 feb 2026, 21:53 UTC

Utili

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 feb 2026, 21:51 UTC

Utili

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb 2026, 21:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

4 feb 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Financial Services Roundup: Market Talk

4 feb 2026, 21:50 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

4 feb 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

4 feb 2026, 21:45 UTC

Utili

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 feb 2026, 21:44 UTC

Utili

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 feb 2026, 21:43 UTC

Utili

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 feb 2026, 21:41 UTC

Utili

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb 2026, 21:36 UTC

Discorsi di Mercato

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 feb 2026, 21:30 UTC

Utili

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb 2026, 21:30 UTC

Utili

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb 2026, 21:30 UTC

Utili

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Confronto tra pari

Modifica del prezzo

Gimv NV Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

171 / 445 Classifica in Finanza

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat